Publications

  1. Wang X, Krambeck AE, Williams JC Jr, Tang X, Rule AD, Zhao F, Bergstralh E, Haskic Z, Edeh S, Holmes DR 3rd, Hernandez LP, Lieske JC. Distinguishing Characteristics of Idiopathic Calcium Oxalate Kidney Stone Formers with Low Amounts of Randall's Plaque. Clin J Am Soc Nephrol. 2014 Oct 7; 9(10):1757-63. Epub 2014 Aug 04.
    View PubMed
  2. Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, Moyer TP. Stone Composition as a Function of Age and Sex. Clin J Am Soc Nephrol. 2014 Oct 02.
    View PubMed
  3. Klee EW, Bondar OP, Goodmanson MK, Trushin SA, Bergstralh EJ, Singh RJ, Anderson NL, Klee GG. Serum Concentrations of Prostate-Specific Antigen Measured Using Immune Extraction, Trypsin Digestion, and Tandem Mass Spectrometry Quantification of LSEPAELTDAVK Peptide. Arch Pathol Lab Med. 2014 Oct; 138(10):1381-6.
    View PubMed
  4. Tang X, Bergstralh EJ, Mehta RA, Vrtiska TJ, Milliner DS, Lieske JC. Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria. Kidney Int. 2014 Sep 17.
    View PubMed
  5. Stewart SB, Cheville JC, Sebo TJ, Frank I, Boorjian SA, Thompson RH, Gettman MT, Tollefson MK, Umbriet EC, Psutka SP, Bergstralh EJ, Rangel L, Karnes RJ. Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Aug 26.
    View PubMed
  6. Karnes RJ, Murphy CR, Bergstralh EJ, DiMonte G, Cheville JC, Lowe VJ, Mynderse LA, Kwon ED. Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Detected by C-Choline Positron Emission Tomography/Computed Tomography. J Urol. 2014 Aug 20.
    View PubMed
  7. Rule AD, Lieske JC, Li X, Melton LJ 3rd, Krambeck AE, Bergstralh EJ. The ROKS Nomogram for Predicting a Second Symptomatic Stone Episode. J Am Soc Nephrol. 2014 Aug 7. [Epub ahead of print]
    View PubMed
  8. Viers BR, Sukov WR, Gettman MT, Rangel LJ, Bergstralh EJ, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Primary Gleason Grade 4 at the Positive Margin Is Associated with Metastasis and Death Among Patients with Gleason 7 Prostate Cancer Undergoing Radical Prostatectomy. Eur Urol. 2014 Jul 19.
    View PubMed
  9. Leedahl DD, Frazee EN, Schramm GE, Dierkhising RA, Bergstralh EJ, Chawla LS, Kashani KB. Derivation of Urine Output Thresholds That Identify a Very High Risk of AKI in Patients with Septic Shock. Clin J Am Soc Nephrol. 2014 Jul 7; 9(7):1168-74. Epub 2014 May 01.
    View PubMed
  10. Viers BR, Cockerill PA, Mehta RA, Bergstralh EJ, Krambeck AE. Extended Antimicrobial Usage Among Patients Undergoing Percutaneous Nephrolithotomy and Associated Antibiotic Related Complications. J Urol. 2014 Jul 03.
    View PubMed
  11. Singh P, Knoedler JJ, Krambeck AE, Lieske JC, Bergstralh EJ, Rule AD. Thiazide Diuretic Prophylaxis for Kidney Stones and the Risk of Diabetes Mellitus. J Urol. 2014 Jun 30.
    View PubMed
  12. Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ, Mrug M, Hogan MC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, Torres VE, the CRISP Investigators. Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials. J Am Soc Nephrol. 2014 Jun 05.
    View PubMed
  13. Knoedler JJ, Karnes RJ, Thompson RH, Rangel LJ, Bergstralh EJ, Boorjian SA. The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Jun; 17(2):144-8. Epub 2014 Jan 28.
    View PubMed
  14. Lorenz EC, Lieske JC, Seide BM, Meek AM, Olson JB, Bergstralh EJ, Milliner DS. Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant. Am J Transplant. 2014 Jun; 14(6):1433-8. Epub 2014 May 02.
    View PubMed
  15. Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A, Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJ, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, Schaeffer EM. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer Prostatic Dis. 2014 Mar; 17(1):64-9. Epub 2013 Oct 22.
    View PubMed
  16. Mikel Hubanks J, Boorjian SA, Frank I, Gettman MT, Houston Thompson R, Rangel LJ, Bergstralh EJ, Jeffrey Karnes R. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. Urol Oncol. 2014 Jan; 32(1):26.e1-7. Epub 2013 Feb 06.
    View PubMed
  17. McCarthy JT, Hocum CL, Albright RC, Rogers J, Gallaher EJ, Steensma DP, Gudgell SF, Bergstralh EJ, Dillon JC, Hickson LJ, Williams AW, Dingli D. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients. Mayo Clin Proc. 2014 Jan; 89(1):87-94.
    View PubMed
  18. Kaushik D, Karnes RJ, Eisenberg MS, Rangel LJ, Carlson RE, Bergstralh EJ. Effect of metformin on prostate cancer outcomes after radical prostatectomy. Urol Oncol. 2014 Jan; 32(1):43.e1-7. Epub 2013 Jun 28.
    View PubMed
  19. Hubanks JM, Boorjian SA, Frank I, Gettman MT, Thompson RH, Rangel LJ, Bergstralh EJ, Karnes RJ. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. UROL. ONCOL. 2014; 32(1):26.e1-7.
  20. Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A, Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJS, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, Schaeffer EM. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer and Prostatic Diseases. 2014; 17(1):64-9.
  21. Ahmed KA, Davis BJ, Mynderse LA, Slezak JM, Bergstralh EJ, Wilson TM, Choo CR. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'. Radiat Oncol. 2014; 9:171. Epub 2014 Jul 29.
    View PubMed
  22. Karnes RJ, Bergstralh EJ, Davicioni E, Ghadessi M, Buerki C, Mitra AP, Crisan A, Erho N, Vergara IA, Lam LL, Carlson R, Thompson DJ, Haddad Z, Zimmermann B, Sierocinski T, Triche TJ, Kollmeyer T, Ballman KV, Black PC, Klee GG, Jenkins RB. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. J Urol. 2013 Dec; 190(6):2047-53. Epub 2013 Jun 11.
    View PubMed
  23. Parker AS, Thiel DD, Bergstralh E, Carlson RE, Rangel LJ, Joseph RW, Diehl N, Karnes RJ. Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies. Prostate Cancer Prostatic Dis. 2013 Dec; 16(4):352-6. Epub 2013 Aug 20.
    View PubMed
  24. Tollefson MK, Boorjian SA, Gettman MT, Rangel LJ, Bergstralh EJ, Karnes RJ. Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy. Urol Oncol. 2013 Nov; 31(8):1483-8. Epub 2012 May 10.
    View PubMed
  25. Eisenberg MS, Karnes RJ, Kaushik D, Rangel L, Bergstralh EJ, Boorjian SA. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy. J Urol. 2013 Nov; 190(5):1735-41. Epub 2013 May 29.
    View PubMed
  26. Berg TM, O'Meara JG, Ou NN, Daniels PR, Moriarty JP, Bergstrahl EJ, Dierkhising RA, Manning DM. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol. Pharmacotherapy. 2013 Nov; 33(11):1165-74. Epub 2013 Apr 26
    View PubMed
  27. Linnes MP, Krambeck AE, Cornell L, Williams JC Jr, Korinek M, Bergstralh EJ, Li X, Rule AD, McCollough CM, Vrtiska TJ, Lieske JC. Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int. 2013 Oct; 84(4):818-25. Epub 2013 May 22.
    View PubMed
  28. Krambeck AE, Lieske JC, Li X, Bergstralh EJ, Rule AD, Holmes D 3rd, McCollough CM, Vrtiska TJ. Current computed tomography techniques can detect duct of Bellini plugging but not Randall's plaques. Urology. 2013 Aug; 82(2):301-6. Epub 2013 Jun 20.
    View PubMed
  29. Linder BJ, Boorjian SA, Umbreit EC, Carlson RE, Rangel LJ, Bergstralh EJ, Karnes RJ. Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer. Int J Urol. 2013 Aug; 20(8):798-805. Epub 2012 Dec 20.
    View PubMed
  30. Tollefson MK, Karnes RJ, Rangel LJ, Bergstralh EJ, Boorjian SA. The impact of clinical stage on prostate cancer survival following radical prostatectomy. J Urol. 2013 May; 189(5):1707-12. Epub 2012 Nov 15.
    View PubMed
  31. Krambeck AE, Lieske JC, Li X, Bergstralh EJ, Melton LJ 3rd, Rule AD. Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population. J Urol. 2013 Jan; 189(1):158-64. Epub 2012 Nov 16.
    View PubMed
  32. Linnes MP, Krambeck AE, Cornell L, Williams JC Jr, Korinek M, Bergstralh EJ, Li X, Rule AD, McCollough CM, Vrtiska TJ, Lieske JC. Re: Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. J Urol. 2013; 190(5):1785.
  33. Bruner B, Nehra A, Rangel L, Bailey C, Bergstralh E, Blute M, Karnes RJ. Association of preoperative testosterone levels with biochemical failure in men undergoing radical prostatectomy. Journal of Men's Health. 2013; 10(4):129-33.
  34. Siddique HR, Parray A, Zhong W, Karnes RJ, Bergstralh EJ, Koochekpour S, Rhim JS, Konety BR, Saleem M. BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer. PLoS One. 2013; 8(1):e52993. Epub 2013 Jan 07.
    View PubMed
  35. Erho N, Crisan A, Vergara IA, Mitra AP, Ghadessi M, Buerki C, Bergstralh EJ, Kollmeyer T, Fink S, Haddad Z, Zimmermann B, Sierocinski T, Ballman KV, Triche TJ, Black PC, Karnes RJ, Klee G, Davicioni E, Jenkins RB. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One. 2013; 8(6):e66855. Epub 2013 Jun 24.
    View PubMed
  36. Boorjian SA, Tollefson MK, Thompson RH, Rangel LJ, Bergstralh EJ, Karnes RJ. Natural history of biochemical recurrence after radical prostatectomy with adjuvant radiation therapy. J Urol. 2012 Nov; 188(5):1761-6. Epub 2012 Sep 19.
    View PubMed
  37. Hogan MC, Masyuk TV, Page L, Holmes DR 3rd, Li X, Bergstralh EJ, Irazabal MV, Kim B, King BF, Glockner JF, Larusso NF, Torres VE. Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrol Dial Transplant. 2012 Sep; 27(9):3532-9. Epub 2012 Jul 06.
    View PubMed
  38. El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol. 2012 Sep; 7(9):1409-15. Epub 2012 Jun 28.
    View PubMed
  39. Pang R, Linnes MP, O'Connor HM, Li X, Bergstralh E, Lieske JC. Controlled metabolic diet reduces calcium oxalate supersaturation but not oxalate excretion after bariatric surgery. Urology. 2012 Aug; 80(2):250-4. Epub 2012 May 02.
    View PubMed
  40. Weight CJ, Kim SP, Karnes RJ, Bergstralh EJ, Cheville JC, Leibovich BC. A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosis. Urology. 2012 Aug; 80(2):484.e17-22. Epub 2012 Apr 13.
    View PubMed
  41. Dwyer ME, Krambeck AE, Bergstralh EJ, Milliner DS, Lieske JC, Rule AD. Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol. 2012 Jul; 188(1):247-52. Epub 2012 May 15.
    View PubMed
  42. Klee EW, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ, Bergen HR 3rd, Sebo TJ, Klee GG. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clin Chem. 2012 Mar; 58(3):599-609. Epub 2012 Jan 12.
    View PubMed
  43. Boorjian SA, Tollefson MK, Rangel LJ, Bergstralh EJ, Karnes RJ. Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy. Prostate Cancer Prostatic Dis. 2012 Mar; 15(1):56-62. Epub 2011 Aug 02.
    View PubMed
  44. de Cogain M, Krambeck AE, Rule AD, Li X, Bergstralh EJ, Gettman MT, Lieske JC. Shock wave lithotripsy and diabetes mellitus: a population-based cohort study. Urology. 2012 Feb; 79(2):298-302. Epub 2011 Nov 16.
    View PubMed
  45. Dimonte G, Bergstralh EJ, Bolander ME, Karnes RJ, Tindall DJ. Use of tumor dynamics to clarify the observed variability among biochemical recurrence nomograms for prostate cancer. Prostate. 2012 Feb; 72(3):280-90. Epub 2011 May 31.
    View PubMed
  46. Inman BA, Frank I, Boorjian SA, Akornor JW, Karnes RJ, Leibovich BC, Blute ML, Bergstralh EJ. Dynamic prediction of metastases after radical prostatectomy for prostate cancer. BJU Int. 2011 Dec; 108(11):1762-8. Epub 2011 May 26.
    View PubMed
  47. Mitchell CR, Umbreit EC, Rangel LJ, Bergstralh EJ, Karnes RJ. Does body mass index "dilute" the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy? Urology. 2011 Oct; 78(4):868-72. Epub 2011 Aug 16.
    View PubMed
  48. Monico CG, Rossetti S, Belostotsky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE, Frishberg Y, Milliner DS. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2289-95.
    View PubMed
  49. Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, McCarthy JT, Nath KA. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1996-2002. Epub 2011 Jul 07.
    View PubMed
  50. Lorenz EC, Lieske JC, Vrtiska TJ, Krambeck AE, Li X, Bergstralh EJ, Melton LJ 3rd, Rule AD. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant. 2011 Aug; 26(8):2695-700. Epub 2011 Feb 01.
    View PubMed
  51. Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM, Blute ML, Buyyounouski MK. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer. 2011 Jul 1; 117(13):2883-91. Epub 2011 Jan 10.
    View PubMed
  52. Uccella S, Cha SS, Melton LJ 3rd, Bergstralh EJ, Boardman LA, Keeney GL, Podratz KC, Ciancio FF, Mariani A. Risk factors for developing multiple malignancies in patients with endometrial cancer. Int J Gynecol Cancer. 2011 Jul; 21(5):896-901.
    View PubMed
  53. McNulty M, Singh RJ, Li X, Bergstralh EJ, Kumar R. Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays. J Clin Endocrinol Metab. 2011 Jul; 96(7):E1159-62. Epub 2011 May 04.
    View PubMed
  54. Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol. 2011 Jun; 59(6):893-9. Epub 2011 Feb 22.
    View PubMed
  55. Tollefson MK, Gettman MT, Blute ML, Bergstralh EJ, Rangel LJ, Karnes RJ. Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy. Urology. 2011 May; 77(5):1161-5. Epub 2010 Dec 03.
    View PubMed
  56. Kumar R, Lieske JC, Collazo-Clavell ML, Sarr MG, Olson ER, Vrtiska TJ, Bergstralh EJ, Li X. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011 May; 149(5):654-61. Epub 2011 Feb 05.
    View PubMed
  57. Ward CJ, Wu Y, Johnson RA, Woollard JR, Bergstralh EJ, Cicek MS, Bakeberg J, Rossetti S, Heyer CM, Petersen GM, Lindor NM, Thibodeau SN, Harris PC, Torres VE, Hogan MC, Boardman LA. Germline PKHD1 mutations are protective against colorectal cancer. Hum Genet. 2011 Mar; 129(3):345-9. Epub 2011 Jan 28.
    View PubMed
  58. Siddiqui SA, Boorjian SA, Blute ML, Rangel LJ, Bergstralh EJ, Karnes RJ, Frank I. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer. BJU Int. 2011 Feb; 107(3):383-8.
    View PubMed
  59. Krambeck AE, Rule AD, Li X, Bergstralh EJ, Gettman MT, Lieske JC. Shock wave lithotripsy is not predictive of hypertension among community stone formers at long-term followup. J Urol. 2011 Jan; 185(1):164-9. Epub 2010 Nov 13.
    View PubMed
  60. Lieske JC, Tremaine WJ, De Simone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb DS. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int. 2010 Dec; 78(11):1178-85. Epub 2010 Aug 25.
    View PubMed
  61. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC, Mayo Nephrology Collaborative Group. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol. 2010 Dec; 5(12):2188-98. Epub 2010 Aug 12.
    View PubMed
  62. Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, Milliner DS, IPHR Investigators. Transplantation outcomes in primary hyperoxaluria. Am J Transplant. 2010 Nov; 10(11):2493-501. Epub 2010 Sep 17.
    View PubMed
  63. Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010 Oct; 21(10):1641-4. Epub 2010 Jul 08.
    View PubMed
  64. Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR 3rd, Rossetti S, Harris PC, LaRusso NF, Torres VE. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol. 2010 Jun; 21(6):1052-61. Epub 2010 Apr 29.
    View PubMed
  65. Tollefson MK, Blute ML, Rangel LJ, Bergstralh EJ, Boorjian SA, Karnes RJ. The effect of Gleason score on the predictive value of prostate-specific antigen doubling time. BJU Int. 2010 May; 105(10):1381-5. Epub 2009 Oct 26.
    View PubMed
  66. Lorenz EC, Vrtiska TJ, Lieske JC, Dillon JJ, Stegall MD, Li X, Bergstralh EJ, Rule AD. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol. 2010 Mar; 5(3):431-8. Epub 2010 Jan 14.
    View PubMed
  67. Boorjian SA, Karnes RJ, Crispen PL, Carlson RE, Rangel LJ, Bergstralh EJ, Blute ML. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol. 2010 Mar; 183(3):1003-9. Epub 2010 Jan 21.
    View PubMed
  68. Doria-Rose VP, Marcus PM, Miller AB, Bergstralh EJ, Mandel JS, Tockman MS, Prorok PC. Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials. Clin Trials. 2010 Feb; 7(1):69-77.
    View PubMed
  69. Saucier NA, Sinha MK, Liang KV, Krambeck AE, Weaver AL, Bergstralh EJ, Li X, Rule AD, Lieske JC. Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis. 2010 Jan; 55(1):61-8. Epub 2009 Oct 22.
    View PubMed
  70. Mariani A, Cha SS, Bergstralh EJ, Boardman LA, Dowdy SC, Keeney GL, Podratz KC, Melton LJ 3rd. Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy. Eur J Gynaecol Oncol. 2010; 31(1):5-9.
    View PubMed
  71. Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Blute ML. Radiation therapy after radical prostatectomy: impact on metastasis and survival. J Urol. 2009 Dec; 182(6):2708-14.
    View PubMed
  72. Gettman MT, Le CQ, Rangel LJ, Slezak JM, Bergstralh EJ, Krambeck AE. Development of a standardized curriculum for teaching cystoscopic skills using a computer-based endourologic simulator. Simul Healthc. 2009 Summer; 4(2):92-7.
    View PubMed
  73. Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009 Apr; 4(4):804-11. Epub 2009 Apr 01.
    View PubMed
  74. Krambeck AE, DiMarco DS, Rangel LJ, Bergstralh EJ, Myers RP, Blute ML, Gettman MT. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques. BJU Int. 2009 Feb; 103(4):448-53. Epub 2008 Sep 03.
    View PubMed
  75. Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Sebo TJ, Blute ML. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol. 2009 Jan; 181(1):95-104; discussion 104. Epub 2008 Nov 13.
    View PubMed
  76. Campbell RL, Luke A, Weaver AL, St Sauver JL, Bergstralh EJ, Li JT, Manivannan V, Decker WW. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol. 2008 Dec; 101(6):631-6.
    View PubMed
  77. Monico CG, Weinstein A, Jiang Z, Rohlinger AL, Cogal AG, Bjornson BB, Olson JB, Bergstralh EJ, Milliner DS, Aronson PS. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis. Am J Kidney Dis. 2008 Dec; 52(6):1096-103. Epub 2008 Oct 31.
    View PubMed
  78. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, Bellolio MF, Bergstralh EJ, Stead LG, Li JT. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008 Dec; 122(6):1161-5. Epub 2008 Nov 06.
    View PubMed
  79. Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, Rangel LJ, Aspinwall R, Niaudet WP, Ozen S, David A, Velinov M, Bergstralh EJ, Bae KT, Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Sampson JR, Dawson BD, Harris PC, CRISP Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int. 2008 Dec; 74(11):1468-79. Epub 2008 Sep 24.
    View PubMed
  80. McCarthy JT, Rule AD, Achenbach SJ, Bergstralh EJ, Khosla S, Melton LJ 3rd. Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc. 2008 Nov; 83(11):1231-9.
    View PubMed
  81. Inman BA, Davies JD, Rangel LJ, Bergstralh EJ, Kwon ED, Blute ML, Karnes RJ, Leibovich BC. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. Cancer. 2008 Oct 1; 113(7):1544-51.
    View PubMed
  82. Cheville JC, Karnes RJ, Therneau TM, Kosari F, Munz JM, Tillmans L, Basal E, Rangel LJ, Bergstralh E, Kovtun IV, Savci-Heijink CD, Klee EW, Vasmatzis G. Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. J Clin Oncol. 2008 Aug 20; 26(24):3930-6.
    View PubMed
  83. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. J Urol. 2008 May; 179(5):1830-7; discussion 1837. Epub 2008 Mar 18.
    View PubMed
  84. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol. 2008 May; 179(5 Suppl):S7-S11.
    View PubMed
  85. Thompson RH, Leibovich BC, Karnes RJ, Bergstralh EJ, Blute ML. Radical retropubic prostatectomy in immunosuppressed transplant recipients. J Urol. 2008 Apr; 179(4):1349-52; discussion 1352-3. Epub 2008 Mar 04.
    View PubMed
  86. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol. 2008 Apr; 179(4):1354-60; discussion 1360-1. Epub 2008 Mar 04.
    View PubMed
  87. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers. BJU Int. 2008 Feb; 101(3):299-304. Epub 2007 Oct 08.
    View PubMed
  88. Gettman MT, Le CQ, Rangel LJ, Slezak JM, Bergstralh EJ, Krambeck AE. Analysis of a computer based simulator as an educational tool for cystoscopy: subjective and objective results. J Urol. 2008 Jan; 179(1):267-71. Epub 2007 Nov 14.
    View PubMed
  89. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int. 2008 Jan; 73(1):117-25. Epub 2007 Oct 17.
    View PubMed
  90. Nakagawa T, Kollmeyer TM, Morlan BW, Anderson SK, Bergstralh EJ, Davis BJ, Asmann YW, Klee GG, Ballman KV, Jenkins RB. A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One. 2008; 3(5):e2318. Epub 2008 May 28.
    View PubMed
  91. Bergstralh EJ, Roberts RO, Farmer SA, Slezak JM, Lieber MM, Jacobsen SJ. Population-based case-control study of PSA and DRE screening on prostate cancer mortality. Urology. 2007 Nov; 70(5):936-41.
    View PubMed
  92. Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol. 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. Epub 2007 Jul 16.
    View PubMed
  93. Thompson RH, Blute ML, Slezak JM, Bergstralh EJ, Leibovich BC. Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? J Urol. 2007 Aug; 178(2):459-63; discussion 463. Epub 2007 Jun 11.
    View PubMed
  94. Berndt T, Thomas LF, Craig TA, Sommer S, Li X, Bergstralh EJ, Kumar R. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci U S A. 2007 Jun 26; 104(26):11085-90. Epub 2007 Jun 12.
    View PubMed
  95. Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, Fradet Y, Lacombe L, Kwon ED. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007 Apr 15; 109(8):1499-505.
    View PubMed
  96. Lieske JC, de la Vega LS, Gettman MT, Slezak JM, Bergstralh EJ, Melton LJ 3rd, Leibson CL. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis. 2006 Dec; 48(6):897-904.
    View PubMed
  97. Siddiqui SA, Sengupta S, Slezak JM, Bergstralh EJ, Zincke H, Blute ML. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol. 2006 Sep; 176(3):1118-21.
    View PubMed
  98. Donadio JV, Bergstralh EJ, Bibus DM, Grande JP. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy? Clin J Am Soc Nephrol. 2006 Sep; 1(5):933-9. Epub 2006 Aug 02.
    View PubMed
  99. Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer. 2006 Aug 1; 107(3):521-9.
    View PubMed
  100. Sengupta S, Christensen CM, Zincke H, Slezak JM, Leibovich BC, Bergstralh EJ, Myers RP, Blute ML. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. J Urol. 2006 Aug; 176(2):559-63.
    View PubMed
  101. Suravarapu S, Bergstralh EJ, Farmer SA, Knopman DS, Jacobsen SJ, Roberts RO. Dementia and low testosterone and bioavailable testosterone levels in men: possible increased risk. Alzheimer Dis Assoc Disord. 2006 Jul-Sep; 20(3):138-40.
    View PubMed
  102. Sengupta S, Slezak JM, Blute ML, Leibovich BC, Sebo TJ, Myers RP, Cheville JC, Bergstralh EJ, Zincke H. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001. Cancer. 2006 Jun 15; 106(12):2630-5.
    View PubMed
  103. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst. 2006 Jun 7; 98(11):748-56.
    View PubMed
  104. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, Fervenza FC. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006 May; 1(3):483-7. Epub 2006 Apr 19.
    View PubMed
  105. Sengupta S, Blute ML, Bagniewski SM, Myers RP, Bergstralh EJ, Leibovich BC, Zincke H. Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival. J Urol. 2006 May; 175(5):1684-90; discussion 1690.
    View PubMed
  106. Roberts RO, Bergstralh EJ, Farmer SA, Jacobson DJ, Hebbring SJ, Cunningham JM, Thibodeau SN, Lieber MM, Jacobsen SJ. Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia. Prostate. 2006 Mar 1; 66(4):392-404.
    View PubMed
  107. Siddiqui SA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Myers RP, Zincke H, Blute ML. Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. J Urol. 2006 Mar; 175(3 Pt 1):952-7.
    View PubMed
  108. Lieske JC, Pena de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006 Feb; 69(4):760-4.
    View PubMed
  109. Mullan RJ, Bergstralh EJ, Farmer SA, Jacobson DJ, Hebbring SJ, Cunningham JM, Thibodeau SN, Lieber MM, Jacobsen SJ, Roberts RO. Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006 Feb; 67(2):300-5.
    View PubMed
  110. Sengupta S, Slezak JM, Blute ML, Bergstralh EJ. Simple graphic method for estimation of prostate-specific antigen doubling time. Urology. 2006 Feb; 67(2):408-9.
    View PubMed
  111. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int. 2006 Jan; 69(2):399-405.
    View PubMed
  112. Sengupta S, Myers RP, Slezak JM, Bergstralh EJ, Zincke H, Blute ML. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. J Urol. 2005 Dec; 174(6):2191-6.
    View PubMed
  113. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol. 2005 Jul; 174(1):107-10; discussion 110-1.
    View PubMed
  114. Lieske JC, Monico CG, Holmes WS, Bergstralh EJ, Slezak JM, Rohlinger AL, Olson JB, Milliner DS. International registry for primary Hyperoxaluria. Am J Nephrol. 2005 May-Jun; 25(3):290-6.
    View PubMed
  115. Mullan RJ, Jacobsen SJ, Bergstralh EJ, Slezak JM, Tindall DJ, Lieber MM, Roberts RO. Decline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000. BJU Int. 2005 May; 95(7):951-5.
    View PubMed
  116. DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol. 2005 Apr; 173(4):1121-5.
    View PubMed
  117. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005 Apr; 95(6):751-6.
    View PubMed
  118. Roberts RO, Bergstralh EJ, Farmer SA, Jacobson DJ, McGree ME, Hebbring SJ, Cunningham JM, Anderson SA, Thibodeau SN, Lieber MM, Jacobsen SJ. Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH. Prostate. 2005 Mar 1; 62(4):380-7.
    View PubMed
  119. Leung N, Slezak JM, Bergstralh EJ, Dispenzieri A, Lacy MQ, Wolf RC, Gertz MA. Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation. Am J Kidney Dis. 2005 Jan; 45(1):102-11.
    View PubMed
  120. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004 Dec 21; 141(12):929-37.
    View PubMed
  121. Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Blute ML. Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. J Urol. 2004 Dec; 172(6 Part 1):2244-8.
    View PubMed
  122. Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Myers RP, Blute ML. The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol. 2004 Oct; 172(4 Part 1):1328-32.
    View PubMed
  123. Roberts RO, Bergstralh EJ, Cunningham JM, Hebbring SJ, Thibodeau SN, Lieber MM, Jacobsen SJ. Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol. 2004 Feb 1; 159(3):269-76.
    View PubMed
  124. Diaz Encarnacion MM, Griffin MD, Slezak JM, Bergstralh EJ, Stegall MD, Velosa JA, Grande JP. Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant. 2004 Feb; 4(2):248-56.
    View PubMed
  125. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, Larson TS. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis. 2004 Jan; 43(1):112-9.
    View PubMed
  126. Roberts RO, Bergstralh EJ, Bass SE, Lieber MM, Jacobsen SJ. Prostatitis as a risk factor for prostate cancer. Epidemiology. 2004 Jan; 15(1):93-9.
    View PubMed
  127. Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol. 2003 Nov; 170(5):1872-6.
    View PubMed
  128. Gyamlani GG, Bergstralh EJ, Slezak JM, Larson TS. Urinary albumin to osmolality ratio predicts 24-hour urine albumin excretion in diabetes mellitus. Am J Kidney Dis. 2003 Oct; 42(4):685-92.
    View PubMed
  129. Soares-Welch CV, Fatourechi V, Bartley GB, Beatty CW, Gorman CA, Bahn RS, Bergstralh EJ, Schleck CD, Garrity JA. Optic neuropathy of Graves disease: Results of transantral orbital decompression and long-term follow-up in 215 patients. Am J Ophthalmol. 2003 Sep; 136(3):433-41.
    View PubMed
  130. Thompson WG, Bergstralh EJ, Slezak JM. Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing. Obes Res. 2003 Aug; 11(8):1027-32.
    View PubMed
  131. Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet. 2003 Jun 28; 361(9376):2196-201.
    View PubMed
  132. Robertson DM, Buettner H, Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh E, Offord KP, Rademacher DM, Stanley NM, Bartley GB. Retinal microvascular abnormalities in patients treated with external radiation for Graves ophthalmopathy. Arch Ophthalmol. 2003 May; 121(5):652-7.
    View PubMed
  133. Roberts RO, Bergstralh EJ, Bass SE, Lightner DJ, Lieber MM, Jacobsen SJ. Incidence of physician-diagnosed interstitial cystitis in Olmsted County: a community-based study. BJU Int. 2003 Feb; 91(3):181-5.
    View PubMed
  134. Colby TV, Tazelaar HD, Travis WD, Bergstralh EJ, Jett JR. Pathologic review of the Mayo Lung Project - Is there a case for misdiagnosis or overdiagnosis of lung carcinoma in the screened group? Cancer. 2002 Dec 1; 95(11):2361-5.
    View PubMed
  135. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Buettner H, Robertson DM, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology. 2002 Nov; 109(11):2100-7.
    View PubMed
  136. Kausik SJ, Blute ML, Sebo TJ, Leibovich BC, Bergstralh EJ, Slezak J, Zincke H. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer. 2002 Sep 15; 95(6):1215-9.
    View PubMed
  137. Bostwick DG, Qian JQ, Pacelli A, Zincke H, Blute M, Bergstralh EJ, Slezak JM, Cheng L. Neuroendocrine expression in node positive prostate cancer: Correlation with systemic progression and patient survival. J Urol. 2002 Sep; 168(3):1204-11.
    View PubMed
  138. Tsuchiya N, Slezak JM, Lieber MM, Bergstralh EJ, Jenkins RB. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer. 2002 Aug; 34(4):363-71.
    View PubMed
  139. Sweat SD, Bergstralh EJ, Slezak J, Blute ML, Zincke H. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol. 2002 Aug; 168(2):525-9.
    View PubMed
  140. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002 Aug; 26(8):879-85.
    View PubMed
  141. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002 Jul; 17(7):1197-203.
    View PubMed
  142. Segni M, Bartley GB, Garrity JA, Bergstralh EJ, Gorman CA. Comparability of proptosis measurements by different techniques. Am J Ophthalmol. 2002 Jun; 133(6):813-8.
    View PubMed
  143. Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol. 2002 May; 13(5):1230-7.
    View PubMed
  144. Velosa JA, Griffin MD, Larson TS, Gloor JM, Schwab TR, Sterioff S, Bergstralh EJ, Stegall MD. Can a transplanted living donor kidney function equivalently to its native partner? Am J Transplant. 2002 Mar; 2(3):252-9.
    View PubMed
  145. Qian J, Hirasawa K, Bostwick DG, Bergstralh EJ, Slezak JM, Anderl KL, Borell TJ, Lieber MM, Jenkins RB. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression. Mod Pathol. 2002 Jan; 15(1):35-44.
    View PubMed
  146. Roberts RO, Bergstralh EJ, Besse JA, Lieber MM, Jacobsen SJ. Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997. Urology. 2002 Jan; 59(1):79-84.
    View PubMed
  147. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol. 2002 Jan; 167(1):117-22.
    View PubMed
  148. Zincke H, Lau W, Bergstralh E, Blute ML. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. J Urol. 2001 Dec; 166(6):2208-15.
    View PubMed
  149. DiMarco DS, LeRoy AJ, Thieling S, Bergstralh EJ, Segura JW. Long-term results of treatment for ureteroenteric strictures. Urology. 2001 Dec; 58(6):909-13.
    View PubMed
  150. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology. 2001 Sep; 108(9):1523-34.
    View PubMed
  151. Xing N, Qian J, Bostwick D, Bergstralh E, Young CY. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Prostate. 2001 Jun 15; 48(1):7-15.
    View PubMed
  152. Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, Gleason DF, Zincke H, Bergstralh EJ, Jacobsen SJ. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer. 2001 Jun 15; 91(12):2302-14.
    View PubMed
  153. Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc. 2001 Jun; 76(6):576-81.
    View PubMed
  154. Roberts WW, Bergstralh EJ, Blute ML, Slezak JM, Carducci M, Han M, Epstein JI, Eisenberger MA, Walsh PC, Partin AW. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology. 2001 Jun; 57(6):1033-7.
    View PubMed
  155. Donadio JV Jr, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol. 2001 Apr; 12(4):791-9.
    View PubMed
  156. Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol. 2001 Apr; 165(4):1146-51.
    View PubMed
  157. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer. 2001 Jan 1; 91(1):66-73.
    View PubMed
  158. Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol. 2001 Jan; 165(1):119-25.
    View PubMed
  159. Roberts RO, Bergstralh EJ, Lieber MM, Jacobsen SJ. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997. Urology. 2000 Nov 1; 56(5):817-22.
    View PubMed
  160. Albright RC Jr, Smelser JM, McCarthy JT, Homburger HA, Bergstralh EJ, Larson TS. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc. 2000 Nov; 75(11):1141-7.
    View PubMed
  161. Blute ML, Bergstralh EJ, Partin AW, Walsh PC, Kattan MW, Scardino PT, Montie JE, Pearson JD, Slezak JM, Zincke H. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol. 2000 Nov; 164(5):1591-5.
    View PubMed
  162. McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products. Am J Nephrol. 2000 Nov-Dec; 20(6):455-62.
    View PubMed
  163. King BF, Reed JE, Bergstralh EJ, Sheedy PF 2nd, Torres VE. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2000 Aug; 11(8):1505-11.
    View PubMed
  164. Cheng L, Slezak J, Bergstralh EJ, Myers RP, Zincke H, Bostwick DG. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Oncol. 2000 Aug; 18(15):2862-8.
    View PubMed
  165. Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J, Zincke H. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued rise of biochemical failure after 5 years. J Urol. 2000 Jul; 164(1):101-105.
    View PubMed
  166. Roberts RO, Bergstralh EJ, Peterson NR, Bostwick DG, Lieber MM, Jacobsen SJ. Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997. J Urol. 2000 May; 163(5):1471-5.
    View PubMed
  167. Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol. 2000 Apr; 163(4):1178-82.
    View PubMed
  168. Cheng L, Pisansky TM, Ramnani DM, Leibovich BC, Cheville JC, Slezak J, Bergstralh EJ, Zincke H, Bostwick DG. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol. 2000 Feb; 13(2):113-8.
    View PubMed
  169. Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC. Lung cancer mortality in the Mayo Lung Project: The impact of extended follow-up. J Natl Cancer Inst. 2000; 92:1308-16.
    View PubMed
  170. Hay ID, Bergstralh EJ, Grant CS, McIver B, Thompson GB, van Heerden JA, Goellner JR. Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery. 1999 Dec; 126(6):1173-81; discussion 1181-2.
    View PubMed
  171. Cheng L, Darson MF, Bergstralh EJ, Slezak J, Myers RP, Bostwick DG. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999 Nov 1; 86(9):1775-82.
    View PubMed
  172. Sato K, Qian J, Slezak JM, Lieber MM, Bostwick DG, Bergstralh EJ, Jenkins RB. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst. 1999 Sep 15; 91(18):1574-80.
    View PubMed
  173. Gettman MT, Pacelli A, Slezak J, Bergstralh EJ, Blute M, Zincke H, Bostwick DG. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma. Urology. 1999 Sep; 54(3):479-85.
    View PubMed
  174. Cheng L, Slezak J, Bergstralh EJ, Cheville JC, Sweat S, Zincke H, Bostwick DG. Dedifferentiation in the metastatic progression of prostate carcinoma. Cancer. 1999 Aug 15; 86(4):657-63.
    View PubMed
  175. Donadio JV Jr, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol. 1999 Aug; 10(8):1772-7.
    View PubMed
  176. Ghavamian R, Blute ML, Bergstralh EJ, Slezak J, Zincke H. Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology. 1999 Jul; 54(1):105-10.
    View PubMed
  177. Cheng L, Cheville JC, Pisansky TM, Sebo TJ, Slezak J, Bergstralh EJ, Neumann RM, Singh R, Pacelli A, Zincke H, Bostwick DG. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999 Jul; 23(7):803-8.
    View PubMed
  178. Cheng L, Leibovich BC, Bergstralh EJ, Scherer BG, Pacelli A, Ramnani DM, Zincke H, Bostwick DG. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer. 1999 Jun 1; 85(11):2455-9.
    View PubMed
  179. Ghavamian R, Bergstralh EJ, Blute ML, Slezak J, Zincke H. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol. 1999 Apr; 161(4):1223-7; discussion 1227-8.
    View PubMed
  180. Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer. J Urol. 1999 Apr; 161(4):1229-32.
    View PubMed
  181. Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Cheng L, Bostwick DG. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. J Urol. 1999 Apr; 161(4):1233-7.
    View PubMed
  182. Cheng L, Sebo TJ, Cheville JC, Pisansky TM, Slezak J, Bergstralh EJ, Pacelli A, Neumann RM, Zincke H, Bostwick DG. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer. 1999 Mar 15; 85(6):1293-9.
    View PubMed
  183. Cheng L, Bergstralh EJ, Scherer BG, Neumann RM, Blute ML, Zincke H, Bostwick DG. Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer. 1999 Mar 15; 85(6):1300-4.
    View PubMed
  184. Roberts RO, Bergstralh EJ, Katusic SK, Lieber MM, Jacobsen SJ. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol. 1999 Feb; 161(2):529-33.
    View PubMed
  185. O'Sullivan DA, Torres VE, Gabow PA, Thibodeau SN, King BF, Bergstralh EJ. Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1998 Dec; 32(6):976-83.
    View PubMed
  186. Cheng L, Bergstralh EJ, Cheville JC, Slezak J, Corica FA, Zincke H, Blute ML, Bostwick DG. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol. 1998 Dec; 22(12):1491-500.
    View PubMed
  187. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998 Dec; 124(6):958-64; discussion 964-6.
    View PubMed
  188. Cheng L, Sebo TJ, Slezak J, Pisansky TM, Bergstralh EJ, Neumann RM, Iczkowski KA, Zincke H, Bostwick DG. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998 Nov 15; 83(10):2164-71.
    View PubMed
  189. Jacobsen SJ, Bergstralh EJ, Katusic SK, Guess HA, Darby CH, Silverstein MD, Oesterling JE, Lieber MM. Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology. 1998 Aug; 52(2):173-9.
    View PubMed
  190. Amling CL, Blute ML, Lerner SE, Bergstralh EJ, Bostwick DG, Zincke H. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. Mayo Clin Proc. 1998 May; 73(5):401-6.
    View PubMed
  191. Blute ML, Bostwick DG, Seay TM, Martin SK, Slezak JM, Bergstralh EJ, Zincke H. Pathologic classification of prostate carcinoma: the impact of margin status. Cancer. 1998 Mar 1; 82(5):902-8.
    View PubMed
  192. Xia Z, Jacobsen SJ, Bergstralh EJ, Chute CG, Katusic SK, Lieber MM. Secular changes in radical prostatectomy utilization rates in Olmsted County, Minnesota 1980 to 1995. J Urol. 1998 Mar; 159(3):904-8.
    View PubMed
  193. Jenkins R, Takahashi S, DeLacey K, Bergstralh E, Lieber M. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Genes Chromosomes Cancer. 1998 Feb; 21(2):131-43.
    View PubMed
  194. Gettman MT, Bergstralh EJ, Blute M, Zincke H, Bostwick DG. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis. Urology. 1998 Jan; 51(1):79-85.
    View PubMed
  195. Blute ML, Bostwick DG, Bergstralh EJ, Slezak JM, Martin SK, Amling CL, Zincke H. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology. 1997 Nov; 50(5):733-9.
    View PubMed
  196. Amling CL, Leibovich BC, Lerner SE, Bergstralh EJ, Blute ML, Myers RP, Zincke H. Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate. Semin Urol Oncol. 1997 Nov; 15(4):215-21.
    View PubMed
  197. Amling CL, Blute ML, Bergstralh EJ, Slezak JM, Martin SK, Zincke H. Preoperative androgen-deprivation therapy for clinical stage T3 prostate cancer. Semin Urol Oncol. 1997 Nov; 15(4):222-9.
    View PubMed
  198. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997 Feb; 8(2):199-207.
    View PubMed
  199. Gloor JM, Breckle RJ, Gehrking WC, Rosenquist RG, Mulholland TA, Bergstralh EJ, Ramin KD, Ogburn PL Jr. Fetal renal growth evaluated by prenatal ultrasound examination. Mayo Clin Proc. 1997 Feb; 72(2):124-9.
    View PubMed
  200. Jacobsen SJ, Bergstralh EJ, Guess HA, Katusic SK, Klee GG, Oesterling JE, Lieber MM. Predictive properties of serum-prostate-specific antigen testing in a community-based setting. Arch Intern Med. 1996 Nov 25; 156(21):2462-8.
    View PubMed
  201. Sinaki M, Wahner HW, Bergstralh EJ, Hodgson SF, Offord KP, Squires RW, Swee RG, Kao PC. Three-year controlled, randomized trial of the effect of dose-specified loading and strengthening exercises on bone mineral density of spine and femur in nonathletic, physically active women. Bone. 1996 Sep; 19(3):233-44.
    View PubMed
  202. Roberts RO, Bergstralh EJ, Schmidt L, Jacobsen SJ. Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol. 1996 Sep; 49(9):989-95.
    View PubMed
  203. Sinaki M, Itoi E, Rogers JW, Bergstralh EJ, Wahner HW. Correlation of back extensor strength with thoracic kyphosis and lumbar lordosis in estrogen-deficient women. Am J Phys Med Rehabil. 1996 Sep-Oct; 75(5):370-4.
    View PubMed
  204. Lerner SE, Jacobsen SJ, Lilja H, Bergstralh EJ, Ransom J, Klee GG, Piironen T, Blute ML, Lieber MM, Zincke H, Pettersson K, Peterson D, Oesterling JE. Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate. Urology. 1996 Aug; 48(2):240-8.
    View PubMed
  205. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol. 1996 Jul; 156(1):137-43.
    View PubMed
  206. Elliott DS, Blute ML, Patterson DE, Bergstralh EJ, Segura JW. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology. 1996 Jun; 47(6):819-25.
    View PubMed
  207. Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, Yemoto C, Stamey TA. The periurethral glands do not significantly influence the serum prostate specific antigen concentration. J Urol. 1996 May; 155(5):1658-60.
    View PubMed
  208. Bostwick DG, Qian J, Bergstralh E, Dundore P, Dugan J, Myers RP, Oesterling JE. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol. 1996 Apr; 155(4):1361-7.
    View PubMed
  209. Lerner SE, Seay TM, Blute ML, Bergstralh EJ, Barrett D, Zincke H. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. J Urol. 1996 Mar; 155(3):821-6.
    View PubMed
  210. Dugan JA, Bostwick DG, Myers RP, Qian J, Bergstralh EJ, Oesterling JE. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA. 1996 Jan 24-31; 275(4):288-94.
    View PubMed
  211. Takahashi S, Alcaraz A, Brown JA, Borell TJ, Herath JF, Bergstralh EJ, Lieber MM, Jenkins RB. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma. Clin Cancer Res. 1996 Jan; 2(1):137-45.
    View PubMed
  212. Katusic SK, Colligan RC, Beard CM, O'Fallon WM, Bergstralh EJ, Jacobsen SJ, Kurland LT. Mental retardation in a birth cohort, 1976-1980, Rochester, Minnesota. Am J Ment Retard. 1996 Jan; 100(4):335-44.
    View PubMed
  213. Jacobsen SJ, Katusic SK, Bergstralh EJ, Oesterling JE, Ohrt D, Klee GG, Chute CG, Lieber MM. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA. 1995 Nov 8; 274(18):1445-9.
    View PubMed
  214. Hawkins CA, Bergstralh EJ, Lieber MM, Zincke H. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy. Urology. 1995 Sep; 46(3):356-64.
    View PubMed
  215. Griffin MD, Bergstralhn EJ, Larson TS. Renal papillary necrosis--a sixteen-year clinical experience. J Am Soc Nephrol. 1995 Aug; 6(2):248-56.
    View PubMed
  216. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab. 1995 Jul; 80(7):2041-5.
    View PubMed
  217. Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus. 1995 Apr; 4(2):109-15.
    View PubMed
  218. Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med. 1994 Dec 8; 331(23):1553-8.
    View PubMed
  219. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med. 1994 Nov 3; 331(18):1194-9.
    View PubMed
  220. Zincke H, Bergstralh EJ, Blute ML, Myers RP, Barrett DM, Lieber MM, Martin SK, Oesterling JE. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol. 1994 Nov; 12(11):2254-63.
    View PubMed
  221. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol. 1994 Nov; 152(5 Pt 2):1850-7.
    View PubMed
  222. Kane LA, Leinung MC, Scheithauer BW, Bergstralh EJ, Laws ER Jr, Groover RV, Kovacs K, Horvath E, Zimmerman D. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab. 1994 Oct; 79(4):1135-40.
    View PubMed
  223. Fatourechi V, Bergstralh EJ, Garrity JA, Bartley GB, Beatty CW, Offord KP, Gorman CA. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy. Mayo Clin Proc. 1994 Sep; 69(9):841-8.
    View PubMed
  224. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res. 1994 Aug 1; 54(15):3998-4002.
    View PubMed
  225. Ferguson J, Zincke H, Ellison E, Bergstrahl E, Bostwick DG. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology. 1994 Jul; 44(1):91-5.
    View PubMed
  226. Kolb LG, Velosa JA, Bergstralh EJ, Offord K. Percutaneous renal allograft biopsy--a comparison of two needle types analysis of risk factors. Transplantation. 1994 Jun 27; 57:1742-1746.
    View PubMed
  227. Velagapudi SR, Frydenberg M, Oesterling JE, Bergstralh EJ, Moore SB, Ruckle HC, Zincke H. Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival. Urology. 1994 Jun; 43(6):821-7.
    View PubMed
  228. Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol. 1994 May; 151(5):1315-20.
    View PubMed
  229. Fatourechi V, Garrity JA, Bartley GB, Bergstralh EJ, DeSanto LW, Gorman CA. Graves ophthalmopathy. Results of transantral orbital decompression performed primarily for cosmetic indications. Ophthalmology. 1994 May; 101(5):938-42.
    View PubMed
  230. McCaffrey TV, Bergstralh EJ, Hay ID. Locally invasive papillary thyroid carcinoma: 1940-1990. Head & Neck. 1994 Mar-Apr; 16(2):165-72.
    View PubMed
  231. Donadio JV, Bergstralh EJ, Offord KP, Holley KE, Spencer DC. Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group. Clin Nephrol. 1994 Feb; 41(2):65-71.
    View PubMed
  232. Cheng WS, Bergstralh EJ, Frydenberg M, Zincke H. Prostate-specific antigen levels after radical prostatectomy and immediate adjuvant hormonal treatment for stage D1 prostate cancer are predictive of early disease outcome. Eur Urol. 1994; 25(3):189-93.
    View PubMed
  233. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993 Dec; 114(6):1050-7; discussion 1057-8.
    View PubMed
  234. Garrity JA, Fatourechi V, Bergstralh EJ, Bartley GB, Beatty CW, DeSanto LW, Gorman CA. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol. 1993 Nov 15; 116(5):533-47.
    View PubMed
  235. Cheng WS, Frydenberg M, Bergstralh EJ, Larson-Keller JJ, Zincke H. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology. 1993 Sep; 42(3):283-91.
    View PubMed
  236. Guthman DA, Wilson TM, Blute ML, Bergstralh EJ, Zincke H, Oesterling JE. Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Urology. 1993 Aug; 42:150-154.
    View PubMed
  237. Petrie RS, Sinaki M, Squires RW, Bergstralh EJ. Physical activity, but not aerobic capacity, correlates with back strength in healthy premenopausal women from 29 to 40 years of age. Mayo Clin Proc. 1993 Aug; 68(8):738-42.
    View PubMed
  238. Fatourechi V, Garrity JA, Bartley GB, Bergstralh EJ, Gorman CA. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema. J Endocrinol Invest. 1993 Jun; 16(6):433-7.
    View PubMed
  239. Fatourechi V, Bartley GB, Garrity JA, Bergstralh EJ, Ebersold MJ, Gorman CA. Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease. Mayo Clin Proc. 1993 Jun; 68(6):552-5.
    View PubMed
  240. Cheng CW, Bergstralh EJ, Zincke H. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy. Cancer. 1993 Feb 1; 71(3 Suppl):996-1004.
    View PubMed
  241. Morgan WR, Bergstralh EJ, Zincke H. Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology. 1993 Feb; 41(2):113-20.
    View PubMed
  242. Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA. 1993 Jan 6; 269(1):57-60.
    View PubMed
  243. Oesterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration Urology. 1993; 42:276-82.
    View PubMed
  244. van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ, Grant CS. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992 Dec; 112(6):1130-6; discussion 1136-8.
    View PubMed
  245. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992 Dec; 112(6):1139-46; discussion 1146-7.
    View PubMed
  246. Gharib H, McConahey WM, Tiegs RD, Bergstralh EJ, Goellner JR, Grant CS, van Heerden JA, Sizemore GW, Hay ID. Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc. 1992 Oct; 67(10):934-40.
    View PubMed
  247. Argueso LR, Ritchey ML, Boyle ET Jr, Milliner DS, Bergstralh EJ, Kramer SA. Prognosis of patients with unilateral renal agenesis. Pediatr Nephrol. 1992 Sep; 6(5):412-6.
    View PubMed
  248. Argueso LR, Ritchey ML, Boyle ET Jr, Milliner DS, Bergstralh EJ, Kramer SA. Prognosis of children with solitary kidney after unilateral nephrectomy. J Urol. 1992 Aug; 148(2 Pt 2):747-51.
    View PubMed
  249. Zincke H, Bergstralh EJ, Larson-Keller JJ, Farrow GM, Myers RP, Lieber MM, Barrett DM, Rife CC, Gonchoroff NJ. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer. 1992 Jul 1; 70(1 Suppl):311-23.
    View PubMed
  250. Pyke CM, Grant CS, Habermann TM, Kurtin PJ, van Heerden JA, Bergstralh EJ, Kunselman A, Hay ID. Non-Hodgkin's lymphoma of the thyroid: is more than biopsy necessary? World J Surg. 1992 Jul-Aug; 16(4):604-9; discussion 609-10.
    View PubMed
  251. Chybowski FM, Bergstralh EJ, Oesterling JE. The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J Urol. 1992 Jul; 148(1):83-6.
    View PubMed
  252. Myers RP, Larson-Keller JJ, Bergstralh EJ, Zincke H, Oesterling JE, Lieber MM. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup. J Urol. 1992 Mar; 147(3 Pt 2):910-5.
    View PubMed
  253. Herrera MF, Hay ID, Wu PSC, Goellner JR, Ryan JJ, Ebersold JR, Berstralh EJ, Grant CS. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 1992; 16:669-675.
    View PubMed
  254. Glenski WJ, Klee GG, Bergstralh EJ, Oesterling JE. Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations. Prostate. 1992; 21(2):99-110.
    View PubMed
  255. Pyke CM, Hay ID, Goellner JR, Bergstralh EJ, van Heerden JA, Grant CS. Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma. Surgery. 1991 Dec; 110(6):964-70; discussion 970-1.
    View PubMed
  256. Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of isopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology. 1991 Sep/Dec; 10:276-281.
    View PubMed
  257. Chute CG, Chuang TY, Bergstralh EJ, Su WP. The subsequent risk of internal cancer with Bowen's disease. A population-based study. JAMA. 1991 Aug 14; 266(6):816-9.
    View PubMed
  258. Leo ME, Bilhartz DL, Bergstralh EJ, Oesterling JE. Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status? J Urol. 1991 Apr; 145(4):802-6.
    View PubMed
  259. Melton LJ 3rd, Bergstralh EJ, Malkasian GD, O'Fallon WM. Bilateral oophorectomy trends in Olmsted County, Minnesota, 1950-1987. Epidemiology. 1991 Mar; 2(2):149-52.
    View PubMed
  260. Marco-Franco JE, Torres VE, Nixon DE, Wilson DM, James EM, Bergstralh EJ, McCarthy JT. Oxalate, silicon and vanadium in acquired cystic kidney disease. Clin Nephrol. 1991 Feb; 35(2):52-8.
    View PubMed
  261. Chybowski FM, Keller JJ, Bergstralh EJ, Oesterling JE. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol. 1991 Feb; 145(2):313-8.
    View PubMed
  262. Nativ O, Bergstralh EJ, Boyle ET, Zincke H. Transurethral resection versus needle biopsy prior to radical prostatectomy for stage c prostate cancer. Urology. 1991 Jan; 37:22-27.
    View PubMed
  263. Calvo MS, Eastell R, Offord KP, Bergstralh EJ, Burritt MF. Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis. J Clin Endocrinol Metab. 1991 Jan; 72(1):69-76.
    View PubMed
  264. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1991 Jan; 66(1):11-22.
    View PubMed
  265. Montgomery BT, Kelalis PP, Blute ML, Bergstralh EJ, Beckwith JB, Norkool P, Green DM, D'Angio GJ. Extended follow-up of bilateral Wilms tumor: Results of the national Wilms Tumor Study. J Urology. 1991; 146:514-8.
  266. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, Bernatz PE, Payne WS, Pairolero PC, Bergstralh EJ. Screening for lung cancer. A critique of the Mayo Lung Project Cancer. 1991; 67:1155-64.
    View PubMed
  267. Katusic S, Williams DB, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of glossopharyngeal neuralgia, Rochester, Minnesota, 1945-1984. Neuroepidemiology. 1991; 10(5-6):266-75.
    View PubMed
  268. Fatourechi V, Bartley GB, DeSanto LW, Harner SG, Bergstralh E, Garrity JA. Efficacy of transantral orbital decompression for the treatment of Graves' optic neuropathy. Thyroid. 1991; 1(Suppl 1):8-12.
  269. Hay ID, Ryan JJ, Grant CS, Bergstralh EJ, van Heerden JA, Goellner JR. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma. Surgery. 1990 Dec; 108(6):972-9; discussion 979-80.
    View PubMed
  270. Kokmen E, Beard CM, Bergstralh E, Anderson JA, Earle JD. Alzheimer's disease and prior therapeutic radiation exposure: a case-control study. Neurology. 1990 Sep; 40(9):1376-9.
    View PubMed
  271. Grant CS, Hay ID, Ryan JJ, Bergstralh EJ, Rainwater LM, Goellner JR. Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World J Surg. 1990 May-Jun; 14(3):283-9; discussion 289-90.
    View PubMed
  272. Bergstralh EJ, Sinaki M, Offord KP, Wahner HW, Melton LJ 3rd. Effect of season on physical activity score, back extensor muscle strength, and lumbar bone mineral density. J Bone Miner Res. 1990 Apr; 5(4):371-7.
    View PubMed
  273. Burritt MF, Slockbower JM, Forsman RW, Offord KP, Bergstralh EJ, Smithson WA. Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc. 1990 Mar; 65(3):329-36.
    View PubMed
  274. Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990 Jan; 27(1):89-95.
    View PubMed
  275. Bruske-Hohlfeld I, Merritt JL, Onofrio BM, Stonnington HH, Offord KP, Bergstralh EJ, Beard CM, Melton LJ 3rd, Kurland LT. Incidence of lumbar disc surgery. A population-based study in Olmsted County, Minnesota, 1950-1979. Spine. 1990 Jan; 15(1):31-5.
    View PubMed
  276. Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989 May; 20(5):577-82.
    View PubMed
  277. Travis WD, Li CY, Bergstralh EJ. Solid and hematologic malignancies in 60 patients with systemic mast cell disease. Archives of Pathology & Laboratory Medicine. 1989 Apr; 113(4):365-8.
    View PubMed
  278. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988 Dec; 104(6):954-62.
    View PubMed
  279. Lufkin EG, Wahner HW, Bergstralh EJ. Reversibility of steroid-induced osteoporosis. Am J Med. 1988 Dec; 85(6):887-8.
    View PubMed
  280. Beard CM, Jedd MB, Woolner LB, Richardson RL, Bergstralh EJ, Melton LJ 3rd. Fifty-year trend in incidence rates of bronchogenic carcinoma by cell type in Olmsted County, Minnesota. J Natl Cancer Inst. 1988 Nov 2; 80(17):1404-7.
    View PubMed
  281. Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore) 1988 Nov; 67(6):345-68.
    View PubMed
  282. Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG. Significance of systemic mast cell disease with associated hematologic disorders. Cancer. 1988 Sep 1; 62(5):965-72.
    View PubMed
  283. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab. 1988 Sep; 67(3):501-8.
    View PubMed
  284. Chuong CJ, Coulam CB, Bergstralh EJ, O'Fallon WM, Steinmetz GI. Clinical trial of naltrexone in premenstrual syndrome. Obstet Gynecol. 1988 Sep; 72(3 Pt 1):332-6.
    View PubMed
  285. Beard CM, Bergstralh EJ, Klee GG. Interobserver variability in collecting data from medical records. Archives of Pathology & Laboratory Medicine. 1988 Jun; 112(6):594-6.
    View PubMed
  286. Chuong CJ, Colligan RC, Coulam CB, Bergstralh EJ. The MMPI as an aid in evaluating patients with premenstrual syndrome. Psychosomatics. 1988; 29:197-202.
    View PubMed
  287. Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW Jr, Melton LJ 3rd. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer. 1987 Nov 1; 60(9):2318-24.
    View PubMed
  288. Michels VV, Bergstralh EJ, Hoverman VR, O'Fallon WM, Weidman WH. Tracking and prediction of blood pressure in children. Mayo Clin Proc. 1987 Oct; 62(10):875-81.
    View PubMed
  289. Dombovy ML, Basford JR, Whisnant JP, Bergstralh EJ. Disability and use of rehabilitation services following stroke in Rochester, Minnesota, 1975-1979. Stroke. 1987 Sep-Oct; 18(5):830-6.
    View PubMed
  290. Lufkin EG, Baldus WP, Bergstralh EJ, Kao PC. Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis. Mayo Clin Proc. 1987 Jun; 62(6):473-9.
    View PubMed
  291. Brutinel WM, Cortese DA, McDougall JC, Gillio RG, Bergstralh EJ. A two-year experience with the neodymium-YAG laser in endobronchial obstruction. Chest. 1987 Feb; 91(2):159-65.
    View PubMed
  292. Laws ER Jr, Bergstralh EJ, Taylor WF. Cerebellar astrocytoma in children. Prog Exp Tumor Res. 1987; 30:122-7.
    View PubMed
  293. Patton PE Coulam CB, Bergstralh E. The prevalence of autoantibodies in pregnant and nonpregnant women. Am J Obstet Gynecol. 1987; 157:1345-50.
    View PubMed
  294. Katusic SK, Beard CM, Wiederholt WC, Bergstralh EJ, Kurland LT. Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982. Ann Neurol. 1986 Nov; 20(5):622-7.
    View PubMed
  295. Podratz RO, Broughton DD, Gustafson DH, Bergstralh EJ, Melton LJ 3rd. Weight loss and body temperature changes in breast-fed and bottle-fed neonates. Clin Pediatr (Phila) 1986 Feb; 25(2):73-7.
    View PubMed
  296. Laws ER Jr, Taylor WF, Bergstralh EJ, Okazaki H, Clifton MB. The neurosurgical management of low-grade astrocytoma. Clin Neurosurg. 1986; 33:575-88.
    View PubMed
  297. McAfee MK, Pairolero PC, Bergstralh EJ, Piehler JM, Unni KK, McLeod RA, Bernatz PE, Payne WS. Chondrosarcoma of the chest wall: factors affecting survival. Ann Thorac Surg. 1985 Dec; 40(6):535-41.
    View PubMed
  298. Chuong CJ, Coulam CB, Kao PC, Bergstralh EJ, Go VL. Neuropeptide levels in premenstrual syndrome. Fertility & Sterility. 1985 Dec; 44(6):760-5.
    View PubMed
  299. Woods JE, Taylor WF, Pritchard DJ, Sim FH, Ivins JC, Bergstralh EJ. Is the BANS concept for malignant melanoma valid? Am J Surg. 1985 Oct; 150(4):452-5.
    View PubMed
  300. Tilley BC, Barnes AB, Bergstralh E, Labarthe D, Noller KL, Colton T, Adam E. A comparison of pregnancy history recall and medical records. Am J Epidemiol. 1985 Feb; 121:269-281.
    View PubMed
  301. Katusic S, Beard CM, Kurland LT, Weis JW, Bergstralh E. Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J Med. 1985 Jan 21; 78(1A):50-5.
    View PubMed
  302. Robboy SJ, Noller KL, O'Brien P, Kaufman RH, Townsend D, Barnes AB, Gundersen J, Lawrence WD, Bergstrahl E, McGorray S. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA. 1984 Dec 7; 252(21):2979-83.
    View PubMed
  303. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg. 1984 Oct; 38(4):331-8.
    View PubMed
  304. Jefferies JA, Robboy SJ, O'Brien PC, Bergstralh EJ, Labarthe DR, Barnes AB, Noller KL, Hatab PA, Kaufman RH, Townsend DE. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. American Journal of Obstetrics & Gynecology. 1984 Jan 1; 148(1):59-66.
    View PubMed
  305. Cortese DA, Pairolero PC, Bergstralh EJ, Woolner LB, Uhlenhopp MA, Piehler JM, Sanderson DR, Bernatz PE, Williams DE, Taylor WF, Payne WS, Fontana RS. Roentgenographically occult lung cancer. A ten-year experience. J Thorac Cardiovasc Surg. 1983 Sep; 86(3):373-80.
    View PubMed
  306. Noller KL, Townsend DE, Kaufman RH, Barnes AB, Robboy SJ, Fish CR, Jefferies JA, Bergstralh EJ, O'Brien PC, McGorray SP, Scully R. Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD Project). American Journal of Obstetrics & Gynecology. 1983 Jun 1; 146(3):279-85.
    View PubMed
  307. Gallagher JC, Melton LJ, Riggs BL, Bergstrath E. Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop. 1980 Jul-Aug; (150):163-71.